Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Natco PharmaNSE:NATCOPHARM +0.32%89 Days Inventory is 535.88 as of Mar. 2026, which is 42% above its 10-year median of 378.17. GuruFocus rates NSE:NATCOPHARM with a GF Score™ of 89/100 and a GF Value™ of ₹924.78 (Fairly Valued). The stock has 2 warning signs investors should review. Among 922 Drug Manufacturers companies, Natco Pharma ranks worse than 93.6% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Natco Pharma's Average Total Inventories for the
three
months ended in Mar. 2026 was ₹9,085 Mil. Natco Pharma's Cost of Goods Sold for the
three
months ended in Mar. 2026 was ₹1,547 Mil.
Hence, Natco Pharma's Days Inventory for the
three
months ended in Mar. 2026 was 535.88.
The historical rank and industry rank for Natco Pharma's Days Inventory or its related term are showing as below:
NSE:NATCOPHARM'
s Days Inventory Range Over the Past 10 Years
Min: 185.71 Med: 378.17 Max: 442.52
Current: 439.15
During the past 13 years, Natco Pharma's highest Days Inventory was 442.52. The lowest was 185.71. And the median was 378.17.
NSE:NATCOPHARM's Days Inventory is ranked worse than 93.6% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.58
vs NSE:NATCOPHARM: 439.15
Natco Pharma's Days Inventory
increased
from Mar. 2025 (280.41) to Mar. 2026 (535.88).
It might indicate that Natco Pharma's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Natco Pharma's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.17.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Natco Pharma's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.23.
Natco Pharma (NSE:NATCOPHARM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Natco Pharma's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Natco Pharma's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Natco Pharma Days Inventory Related Terms
Natco Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Natco Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NATCOPHARM vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Natco Pharma Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Natco Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Natco Pharma (NSE:NATCOPHARM) has a Days Inventory of 535.88 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Natco Pharma and its competitors. This is 42% above median its historical median of 378.17. Over the past decade, Natco Pharma's Days Inventory has ranged from 185.71 to 442.52. According to the industry distribution chart, Natco Pharma ranks #863 out of 922 companies in the Drug Manufacturers industry, placing it in the top 93.6%.
Is Natco Pharma's Days Inventory too high?
Natco Pharma's current Days Inventory of 535.88 is 42% above median its 10-year median of 378.17. Over the past 10 years, this metric has ranged from a low of 185.71 to a high of 442.52. The Drug Manufacturers industry median Days Inventory is 164.58. Natco Pharma's value of 535.88 is 225.6% above this industry median. Based on the distribution chart, Natco Pharma ranks #863 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Natco Pharma has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Natco Pharma's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Natco Pharma ranks #863 out of 922 companies for Days Inventory. This places Natco Pharma in the lower half of its industry. The industry median Days Inventory is 164.58. Natco Pharma's value of 535.88 is 225.6% above this benchmark. Historically, Natco Pharma's own Days Inventory has ranged from 185.71 to 442.52 over the past decade. While the company's 10-year median is 378.17 vs. the industry median of 164.58, Natco Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.58, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Natco Pharma's current Days Inventory of 535.88 is 225.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Natco Pharma and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Natco Pharma's current Days Inventory is 535.88, which is 42% above median its own 10-year median of 378.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natco Pharma stock overvalued right now?
Based on GuruFocus' analysis, Natco Pharma (NSE:NATCOPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹924.78, compared to a current price of ₹921.45 — trading 0.4% below its estimated fair value. The current Days Inventory is 535.88, which is 42% above median its 10-year median of 378.17 and 225.6% above the Drug Manufacturers industry median of 164.58. Natco Pharma's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Natco Pharma (NSE:NATCOPHARM), the current Days Inventory is 535.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Natco Pharma (NSE:NATCOPHARM) Overvalued in 2026?
Based on GuruFocus' analysis, Natco Pharma stock appears to be undervalued.
The current stock price of ₹921.45 is trading 0.4% below its estimated GF Value™ of ₹924.78.
GuruFocus considers Natco Pharma to be Fairly Valued.
Key valuation signals for NSE:NATCOPHARM:
Days Inventory: 535.88 (42% above median its 10-year median of 378.17)
GF Value™: ₹924.78 vs. price of ₹921.45 (0.4% below fair value)
Industry Position: 225.6% above the Drug Manufacturers median (#863 of 922)
No single metric tells the full story. See the NSE:NATCOPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Natco Pharma Ltd is a drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. It derives maximum revenue from Pharmaceuticals Segment.
89GF Score
Get the complete analysis for NSE:NATCOPHARM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NATCOPHARM has been successfully added to your 
